CymitQuimica logo
Cell Cycle/Checkpoint

Cell Cycle/Checkpoint

Cell cycle/checkpoint inhibitors are compounds that disrupt the normal progression of the cell cycle, particularly at key regulatory checkpoints. These inhibitors are crucial for studying cell division, understanding cancer cell proliferation, and developing anti-cancer therapies. By targeting specific phases of the cell cycle, these inhibitors can induce cell cycle arrest, leading to apoptosis or senescence in rapidly dividing cells. At CymitQuimica, we offer a diverse range of high-quality cell cycle/checkpoint inhibitors to support your research in cancer biology, cell biology, and drug development.

Subcategories of "Cell Cycle/Checkpoint"

Show 10 more subcategories

Found 3730 products of "Cell Cycle/Checkpoint"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • (S)-AM-9022

    CAS:
    (S)-AM-9022 is the S-enantiomer of AM-9022, which is a potent and selective KIF18A inhibitor with oral bioavailability, applicable in cancer research.
    Formula:C27H36F2N6O4S
    Molecular weight:578.67
  • 6-Amino-4-hydrozino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine


    6-Amino-4-hydrozino-2-(β-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine is a purine nucleoside analogue with broad antitumor activity, particularly against
    Formula:C10H15N7O4
    Color and Shape:Solid
    Molecular weight:297.27
  • 1-(β-D-Xylofuranosyl)-N6-Isopentenyladenine


    <p>1-(β-D-Xylofuranosyl)-N6-Isopentenyladenine is an adenosine analog.</p>
    Formula:C15H21N5O4
    Color and Shape:Solid
    Molecular weight:335.36
  • Methylcarbamyl PAF C-8


    Methylcarbamyl PAF C-8 is resistant to degradation by PAF-AH and has a half-life of over 100 minutes in platelet-poor plasma, exhibiting platelet aggregation activity. In NRK-49 cells overexpressing PAF receptor, it induces the expression of c-myc, c-fos, and activates mitogen-activated protein kinase (MAPK). Furthermore, Methylcarbamyl PAF C-8 can induce G1 phase cell cycle arrest. This compound shows potential for research in cardiovascular and anti-cancer applications.
    Color and Shape:Odour Solid
  • Guanosine 5'-triphosphate trisodium salt hydrate

    CAS:
    5'-GTP trisodium salt hydrate activates G proteins and is a precursor for DNA/RNA synthesis.
    Formula:C10H18N5NaO15P3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:564.185
  • m7GpppUmpG

    CAS:
    m7GpppUmpG, a trinucleotide cap analogue, enables RNA synthesis with cap 0 or 1 structures.
    Formula:C31H42N12O26P4
    Color and Shape:Solid
    Molecular weight:1122.63
  • SP27


    <p>SP27, a selective PROTAC, degrades PLK4 with a DC50 of 19.5 nM and may be utilized in breast cancer research [1].</p>
    Formula:C40H40F2N12O5
    Purity:98%
    Color and Shape:Solid
    Molecular weight:806.82
  • Rev 2'-O-MOE-C(Bz)-5'-amidite


    'Rev 2’-O-MOE-C(Bz)-5’-amidite, a purine nucleoside analog, exhibits broad antitumor activity against indolent lymphoid malignancies.
    Formula:C49H58N5O10P
    Color and Shape:Solid
    Molecular weight:907.99
  • Ribonuclease T1

    CAS:
    <p>Rnase T1, an endonuclease, degrades single-stranded RNA to yield 3'-GMP oligonucleotides.</p>
    Color and Shape:Solid
  • 1-(β-D-Xylofuranosyl)-N6-(m-methoxybenzyl)adenine


    1-(β-D-Xylofuranosyl)-N6-(m-methoxybenzyl)adenine is an adenosine analog.
    Formula:C18H21N5O5
    Color and Shape:Solid
    Molecular weight:387.39
  • LDV

    CAS:
    α4β1 integrin (VLA-4) ligand (Kd ~ 12 nM). Non-fluorescent derivative of LDV FITC.
    Formula:C48H70N10O12
    Purity:98%
    Color and Shape:Solid
    Molecular weight:979.13
  • Confidential-2


    Confidential-2: a purine nucleoside analog with antitumor effects on lymphoid cancers, inhibits DNA synthesis, induces apoptosis.
    Formula:C20H25N5O8
    Color and Shape:Solid
    Molecular weight:463.44
  • PROTAC CDK9 degrader-5

    CAS:
    PROTAC CDK9 degrader-5 selectively degrades CDK9 isoforms 42, 55 with DC50 of 0.10μM, 0.14μM via proteasome.
    Formula:C42H48Cl2N8O9
    Purity:98%
    Color and Shape:Solid
    Molecular weight:879.78
  • LL-K8-22


    LL-K8-22: potent CDK8/cyclin C degrader; DC50 ~2.5μM; hinders STAT1 phosphorylation; curbs E2F/MYC cancer pathways; for TNBC study.
    Formula:C37H43N5O
    Color and Shape:Solid
    Molecular weight:573.77
  • 6-Amino-4-methoxy-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine

    CAS:
    6-Amino-4-methoxy-1-(2-deoxy-β-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine, a pyrimidine nucleoside analog, exhibits a broad spectrum of biochemical and
    Formula:C11H15N5O4
    Color and Shape:Solid
    Molecular weight:281.27
  • Censavudine

    CAS:
    <p>Censavudine (OBP-601) is an HIV-1/2 treatment and prevention drug, a reverse transcriptase inhibitor with EC50 of 30-890 nM.</p>
    Formula:C12H12N2O4
    Purity:98%
    Color and Shape:Solid
    Molecular weight:248.23
  • 4-Amino-1-(β-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine-5-carboxamide


    4-Amino-1-(β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide is a purine nucleoside analog with broad antitumor activity against indolent lymphoid
    Formula:C12H15N5O5
    Color and Shape:Solid
    Molecular weight:309.28
  • Aurora-A ligand 1

    CAS:
    <p>Aurora-A ligand 1 is a potent and selective inhibitor of Aurora-A, exhibiting a dissociation constant (Kd) of 0.85 nM. It serves as a target protein ligand [PROTAC target protein ligand] in the development of PROTAC Aurora-A degraders with antitumor activity. Additionally, Aurora-A ligand 1 is utilized in the synthesis of HLB-0532259, which exhibits antitumor effects against neuroblastoma.</p>
    Formula:C21H23N5O3
    Color and Shape:Solid
    Molecular weight:393.439
  • SMS 121

    CAS:
    SMS 121 is a novel CD36 inhibitor that impairs fatty acid uptake and cell viability in acute myeloid leukaemia (AML) cells.
    Formula:C20H21NO5
    Purity:98.29%
    Color and Shape:Soild
    Molecular weight:355.38
  • WRN inhibitor 10


    WRN inhibitor 10 (Compound P24) is an inhibitor of the Werner helicase WRN, with an IC50 of 1.1 nM. It effectively inhibits the proliferation of SW48 cancer cells, with an IC50 of 39 nM. WRN inhibitor 10 exhibits favorable liver microsomal stability and membrane permeability, and demonstrates good pharmacokinetic properties in CD-1 mice.
    Formula:C31H29BrClN9O5S
    Molecular weight:753.08843